title: Topical lithium succinate ointment (Efalith) in the treatment of AIDS-related seborrhoeic dermatitis.
abstract: A randomised, double-blind, placebo-controlled trial with lithium succinate ointment was conducted in patients with AIDS-associated facial seborrhoeic dermatitis. Twice daily applications of the ointment brought about a rapid (2.5 days) and highly significant (P = 0.007) improvement in the severity of the condition. Lithium succinate ointment is well tolerated and can be a useful treatment for seborrhoeic dermatitis in this group of patients.
authors.affiliation: Department of Dermatology, Westminster Hospital, London, UK.
authors.forename: J A
authors.initials: JA
authors.lastname: Langtry
authors.forename: C M
authors.initials: CM
authors.lastname: Rowland Payne
authors.forename: R C
authors.initials: RC
authors.lastname: Staughton
authors.forename: J C
authors.initials: JC
authors.lastname: Stewart
authors.forename: D F
authors.initials: DF
authors.lastname: Horrobin
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D012628:Dermatitis, Seborrheic / Q000188:drug therapy* / Q000209:etiology; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D005148:Facial Dermatoses / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D018020:Lithium Compounds / Q000627:therapeutic use*; D008297:Male; D009824:Ointments; D016896:Treatment Outcome
chemical_list: D003879:Dermatologic Agents; D018020:Lithium Compounds; D009824:Ointments